BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1350989)

  • 1. In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783.
    Vaugeois JM; Bonnet JJ; Costentin J
    Eur J Pharmacol; 1992 Jan; 210(1):77-84. PubMed ID: 1350989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion.
    Vaugeois JM; Bonnet JJ; Duterte-Boucher D; Costentin J
    Eur J Pharmacol; 1993 Jan; 230(2):195-201. PubMed ID: 8422901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
    Richfield EK
    Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo binding of [3H]GBR 12783, a selective dopamine uptake inhibitor, in mouse striatum.
    Chagraoui A; Bonnet JJ; Protais P; Costentin J
    Neurosci Lett; 1987 Jul; 78(2):175-9. PubMed ID: 3627558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
    Héron C; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1994 Nov; 264(3):391-8. PubMed ID: 7698180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system.
    Bonnet JJ; Protais P; Chagraoui A; Costentin J
    Eur J Pharmacol; 1986 Jul; 126(3):211-22. PubMed ID: 3489625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sites.
    Refahi-Lyamani F; Saadouni S; Costentin J; Bonnet JJ
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):136-45. PubMed ID: 7770096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
    Xu C; Coffey LL; Reith ME
    Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of [3H]GBR 12935 and GBR 12909 with the dopamine uptake complex in nucleus accumbens.
    Berger P; Elsworth JD; Arroyo J; Roth RH
    Eur J Pharmacol; 1990 Feb; 177(1-2):91-4. PubMed ID: 1967129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.
    Niznik HB; Tyndale RF; Sallee FR; Gonzalez FJ; Hardwick JP; Inaba T; Kalow W
    Arch Biochem Biophys; 1990 Feb; 276(2):424-32. PubMed ID: 2306106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex.
    Andersen PH
    J Neurochem; 1987 Jun; 48(6):1887-96. PubMed ID: 2952763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
    Berger SP; Martenson RE; Laing P; Thurkauf A; Decosta B; Rice KC; Paul SM
    Mol Pharmacol; 1991 Apr; 39(4):429-35. PubMed ID: 2017146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]GBR 12935 binding to human platelet membranes is sensitive to piperazine derivatives but not to dopamine uptake inhibitors.
    Gordon I; Weizman R; Rehavi M
    Life Sci; 1994; 55(3):189-99. PubMed ID: 8007761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol.
    Bonnet JJ; Benmansour S; Costentin J; Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1206-14. PubMed ID: 2141637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action.
    Andersen PH
    Eur J Pharmacol; 1989 Aug; 166(3):493-504. PubMed ID: 2530094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935.
    Reith ME; Selmeci G
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):309-18. PubMed ID: 1620235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier.
    Saadouni S; Refahi-Lyamani F; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1994 Jul; 268(2):187-97. PubMed ID: 7957640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacological comparison of [3H]GBR12935 binding to rodent striatal and kidney homogenates: binding to dopamine transporters?
    Sharif NA; Nunes JL; Kalfayan V; McClelland DL; Rosenkranz RP; Eglen RM; Whiting RL
    Neurochem Int; 1992 Jul; 21(1):69-73. PubMed ID: 1303143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+.
    Bonnet JJ; Benmansour S; Amejdki-Chab N; Costentin J
    Eur J Pharmacol; 1994 Jan; 266(1):87-97. PubMed ID: 8137886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex.
    Janowsky A; Berger P; Vocci F; Labarca R; Skolnick P; Paul SM
    J Neurochem; 1986 Apr; 46(4):1272-6. PubMed ID: 3081686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.